Originally used in medicine as an anti-hemorrhagic agent, its skin brightening potential was discovered by accident
Quality and Safety: What to Verify The 2012 NECC disaster demonstrated that not all compounding pharmacies maintain adequate quality controls
JainABuistNRKennawayNGPowellBRAuldPAMrtenssonJ
But, does that mean that medicine is right for you
Results of more studies testing the SGLT-2 inhibitor sotagliflozin in people with type 1 diabetes, continued to be encouraging: Sotagliflozin reduced A1C and body weight, lowered insulin doses, and caused fewer episodes of severe hypoglycemia compared to control groups
This process results in the upregulation of tissue factor (TF), which activates the extrinsic coagulation pathway, leading to increased thrombin generation, fibrin deposition, and the formation of microthrombi